White label – Pompe disease - ClinicalTrials.eu

A study comparing mifamurtide to sorafenib for treating high-risk osteosarcoma in children and young adults

Recruiting

2 1 1 1
Investigated Diseases:
- Osteosarcoma
Investigated Drugs:
- Mifamurtide
- Sorafenib
A study to evaluate the safety and effectiveness of darizmetinib hydrochloride in patients who have had liver surgery due to colon cancer metastases

Recruiting

1 1
Investigated Diseases:
- Colon cancer
- Colon cancer stage III
A study on the long-term safety and effectiveness of giroctocogene fitelparvovec or fidanacogene elaparvovec in patients with hemophilia A or hemophilia B

Recruiting

3 1 1
Investigated Diseases:
- Factor IX deficiency
- Factor VIII deficiency
Investigated Drugs:
- Fidanacogene Elaparvovec
- Giroctocogene Fitelparvovec
A study to evaluate the efficacy and safety of trospium chloride and xanomeline tartrate for the treatment of schizophrenia in adolescents aged 13 to 17 years

Recruiting

3 1
Investigated Drugs:
- Trospium Chloride
- Xanomeline Tartrate
A study to evaluate the effectiveness and safety of vamifeport in adults with hereditary hemochromatosis

Recruiting

2 1
Investigated Drugs:
- VAMIFEPORT TRIHYDROCHLORIDE
+5
A study to evaluate the safety and how pivekimab sunirine works in children with relapsed or refractory acute myeloid leukemia

Recruiting

1 1 1
Investigated Diseases:
- Acute myeloid leukaemia
Investigated Drugs:
- Pivekimab Sunirine
A study of loxo-435, enfortumab vedotin, and pembrolizumab in adults with advanced or metastatic bladder cancer

Recruiting

3 1 1
Investigated Diseases:
- Bladder transitional cell carcinoma
- Bladder cancer
Investigated Drugs:
+3
A study of sacituzumab tirumotecan versus docetaxel, paclitaxel, or vinflunine for patients with pretreated advanced or metastatic bladder cancer

Recruiting

3 1 1 1
Investigated Drugs:
+2
A Phase 3 Study of Elritercept Versus Epoetin Alfa in ESA‑Naïve Adults with Lower‑Risk Myelodysplastic Syndrome Requiring Red Blood Cell Transfusions

Recruiting

3 1 1 1
Investigated Drugs:
- Elritercept
- Epoetin Alfa
+8
Phase 3 Study of INCB123667 versus investigator’s choice of chemotherapy drug combination in patients with platinum‑resistant ovarian cancer and cyclin E1 overexpression

Recruiting

3 1 1 1
Investigated Drugs:
+2

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies